# Section 232
Latest news and articles about Section 232
Total: 4 articles found
A Bitter Pill: Trump’s 100% Drug Tariffs and the Future of Chinese Biotech
President Trump has signed an executive order under Section 232 to impose 100% tariffs on imported patent drugs and APIs, aimed at forcing price concessions and manufacturing onshoring. While Chinese biotech firms face new challenges, many are already pivoting toward U.S.-based production to mitigate these trade risks.
Trump’s Tariff Sleight of Hand: A Nominal Cut, a Real-World Hike
The Trump administration plans to overhaul steel and aluminum tariffs by applying a 25% rate to the total value of finished goods rather than a 50% rate on their metal content. While the nominal rate is lower, the shift to a broader valuation base is expected to increase the total tax burden on importers and simplify compliance.
Washington Threatens 15% Global Import Duty This Week, Renewing Trade Uncertainty for China and Allies
U.S. officials indicated a temporary global import duty could rise from 10% to 15% imminently, a move designed to replace tariffs the Supreme Court found legally unsupported. The administration says it will seek to reinstate higher, more defensible tariffs within five months using other trade statutes, a plan that has unsettled markets and alarmed trade partners.
Washington’s Tariff Pivot: 15% for Some Partners, No New China Levies Ahead of Trump Visit
After a Supreme Court rebuke of its earlier emergency tariff plan, the U.S. administration has implemented a 10% global temporary tariff and signalled it will raise duties to 15% or more for selected countries while publicly sparing China ahead of a planned Trump visit. Officials plan to rely on Section 301 investigations and other statutes, including Section 232 and Section 338, to justify targeted, more permanent levies — a strategy that heightens uncertainty for trading partners and global supply chains.